← Leaderboards
Scott T Weiss
University Of California, San Diego
$73,772,324
Attributed
$133,958,332
Total exposure
28
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $17.2M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$197,293,178 · 31
By mechanism
U01$59,429,269 · 5
P01$31,104,070 · 8
R01$25,196,000 · 7
OT2$24,332,058 · 2
R37$14,567,368 · 1
UH3$13,509,710 · 1
Top collaborators
- Edwin K Silverman21 shared
- Augusto A Litonjua18 shared
- Elizabeth W Karlson14 shared
- Shawn N Murphy14 shared
- Jordan W Smoller14 shared
- Kelan G Tantisira8 shared
- Lester Kobzik5 shared
- George T O'Connor4 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Robin Knight$23,265,798
- Rain G Bosworth$2,197,502
Others in their field
Top investigators on “Asthma”
- James E. Gern · University Of Wisconsin-Madison$159,588,264
- William W. Busse · University Of Wisconsin Madison$104,093,792
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$79,309,576
- Fernando D Martinez · University Of Arizona$66,357,737
- Wanda Phipatanakul · Boston Children'S Hospital$50,505,446
- Joshua A Boyce · Brigham And Women'S Hospital$45,961,764
Research focus
AsthmaProgramsGeneticGenomicsPhenotypeGenotypeResearch PersonnelChildAffectBaseComplexMorbidity - Disease RateLeadGenome Wide Association StudyVariantLung DiseasesGenesMolecularCandidate Disease GeneHealth Care CostsBioinformaticsLifeChildhood AsthmaClinical Trials
Grant awards (159)
Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping$2,137,425
R01 · FY2025 · HL
SYSTEMS APPROACHES TO THE EPIDEMIOLOGY, GENETICS AND GENOMICS OF LUNG DISEASES$632,644
T32 · FY2025 · HL · contact PI
Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping$2,102,471
R01 · FY2024 · HL
SYSTEMS APPROACHES TO THE EPIDEMIOLOGY, GENETICS AND GENOMICS OF LUNG DISEASES$765,252
T32 · FY2024 · HL · contact PI
SYSTEMS APPROACHES TO THE EPIDEMIOLOGY, GENETICS AND GENOMICS OF LUNG DISEASES$722,163
T32 · FY2023 · HL · contact PI
The New England Precision Medicine Consortium of the All of Us Research Program$9,700,000
OT2 · FY2022 · OD
Multi-omic approaches to mechanisms of vitamin D, environmental influences, and the microbiome on asthma$2,629,203
UH3 · FY2022 · OD · contact PI
Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping$2,115,286
R01 · FY2022 · HL
SYSTEMS APPROACHES TO THE EPIDEMIOLOGY, GENETICS AND GENOMICS OF LUNG DISEASES$706,416
T32 · FY2022 · HL · contact PI
Multi-omic approaches to mechanisms of vitamin D, environmental influences, and the microbiome on asthma$2,631,050
UH3 · FY2021 · OD · contact PI
eMERGE Phase IV Clinical Center at Mass General Brigham$1,415,570
U01 · FY2021 · HG
SYSTEMS APPROACHES TO THE EPIDEMIOLOGY, GENETICS AND GENOMICS OF LUNG DISEASES$704,854
T32 · FY2021 · HL · contact PI
Multi-omic approaches to mechanisms of vitamin D, environmental influences, and the microbiome on asthma$2,631,050
UH3 · FY2020 · OD · contact PI
Systems Biology of Airway Disease$2,616,894
P01 · FY2020 · HL · contact PI
eMERGE Phase IV Clinical Center at Partners HealthCare$1,216,161
U01 · FY2020 · HG
eMERGE Phase IV Clinical Center at Partners HealthCare$883,131
U01 · FY2020 · HG
Genetic Determinants of Asthma and COPD$694,045
P01 · FY2020 · HL · contact PI
Finding Genomic Profiles of COVID-19 Phenotypes from the EHR$401,928
U01 · FY2020 · HG
SYSTEMS APPROACHES TO THE EPIDEMIOLOGY, GENETICS AND GENOMICS OF LUNG DISEASES$311,077
T32 · FY2020 · HL · contact PI
CORE D: ADMINISTRATIVE CORE$148,537
P01 · FY2020 · HL · contact PI
The New England Precision Medicine Consortium of the All of Us Research Program$10,000,000
OT2 · FY2019 · OD
Multi-omic approaches to mechanisms of vitamin D, environmental influences, and the microbiome on asthma$2,978,876
UH3 · FY2019 · OD · contact PI
Systems Biology of Airway Disease$2,293,621
P01 · FY2019 · HL · contact PI
EMERGE PHASE III CLINICAL CENTER AT PARTNERS HEALTHCARE$800,708
U01 · FY2019 · HG · contact PI
SYSTEMS APPROACHES TO THE EPIDEMIOLOGY, GENETICS AND GENOMICS OF LUNG DISEASES$649,411
T32 · FY2019 · HL · contact PI
Genetic Determinants of Asthma and COPD$303,613
P01 · FY2019 · HL · contact PI
CORE D: ADMINISTRATIVE CORE$159,731
P01 · FY2019 · HL · contact PI
Multi-omic approaches to mechanisms of vitamin D, environmental influences, and the microbiome on asthma$2,639,531
UH3 · FY2018 · OD · contact PI
Systems Biology of Airway Disease$2,411,769
P01 · FY2018 · HL · contact PI
RANDOMIZED CONTROLLED TRIAL: VDAART CONTINUATION STUDY - DCC - LEAD$1,175,714
R01 · FY2018 · HL · contact PI
EMERGE PHASE III CLINICAL CENTER AT PARTNERS HEALTHCARE$953,224
U01 · FY2018 · HG · contact PI
SYSTEMS APPROACHES TO THE EPIDEMIOLOGY, GENETICS AND GENOMICS OF LUNG DISEASES$652,625
T32 · FY2018 · HL · contact PI
Integrative & Systems Genomics Core$483,323
P01 · FY2018 · HL · contact PI
Genetic Determinants of Asthma and COPD$303,795
P01 · FY2018 · HL · contact PI
CORE D: ADMINISTRATIVE CORE$156,364
P01 · FY2018 · HL · contact PI
A New England Enrollment Center for PMI Cohort Program$3,420,872
OT2 · FY2017 · OD
Systems Biology of Airway Disease$2,559,949
P01 · FY2017 · HL · contact PI
Multi-omic approaches to mechanisms of vitamin D, environmental influences, and the microbiome on asthma$2,293,579
UG3 · FY2017 · OD · contact PI
RANDOMIZED CONTROLLED TRIAL: VDAART CONTINUATION STUDY - DCC - LEAD$1,940,233
R01 · FY2017 · HL · contact PI
EMERGE PHASE III CLINICAL CENTER AT PARTNERS HEALTHCARE$916,160
U01 · FY2017 · HG · contact PI
SYSTEMS APPROACHES TO THE EPIDEMIOLOGY, GENETICS AND GENOMICS OF LUNG DISEASES$628,144
T32 · FY2017 · HL · contact PI
Integrative & Systems Genomics Core$483,988
P01 · FY2017 · HL · contact PI
SYSTEMS GENETICS AND GENOMICS OF LUNG DISEASES$342,898
K12 · FY2017 · HL · contact PI
Genetic Determinants of Asthma and COPD$300,236
P01 · FY2017 · HL · contact PI
CORE D: ADMINISTRATIVE CORE$152,805
P01 · FY2017 · HL · contact PI
EMERGE PHASE III CLINICAL CENTER AT PARTNERS HEALTHCARE$100,000
U01 · FY2017 · HG · contact PI
SYSTEMS APPROACHES TO THE EPIDEMIOLOGY, GENETICS AND GENOMICS OF LUNG DISEASES$2,592
T32 · FY2017 · HL · contact PI
Systems Biology of Airway Disease$2,702,068
P01 · FY2016 · HL · contact PI
RANDOMIZED CONTROLLED TRIAL: VDAART CONTINUATION STUDY - DCC - LEAD$1,979,924
R01 · FY2016 · HL · contact PI
A New England Enrollment Center for PMI Cohort Program$1,211,186
OT2 · FY2016 · OD
EMERGE PHASE III CLINICAL CENTER AT PARTNERS HEALTHCARE$953,224
U01 · FY2016 · HG · contact PI
SYSTEMS APPROACHES TO THE EPIDEMIOLOGY, GENETICS AND GENOMICS OF LUNG DISEASES$629,634
T32 · FY2016 · HL · contact PI
Multi-omic approaches to mechanisms of vitamin D, environmental influences, and the microbiome on asthma$499,030
UG3 · FY2016 · OD · contact PI
Integrative & Systems Genomics Core$484,633
P01 · FY2016 · HL · contact PI
SYSTEMS GENETICS AND GENOMICS OF LUNG DISEASES$336,824
K12 · FY2016 · HL · contact PI
Genetic Determinants of Asthma and COPD$297,288
P01 · FY2016 · HL · contact PI
CORE D: ADMINISTRATIVE CORE$148,080
P01 · FY2016 · HL · contact PI
RANDOMIZED CONTROLLED TRIAL: VDAART CONTINUATION STUDY - DCC - LEAD$1,984,868
R01 · FY2015 · HL · contact PI
The Genetic Epidemiology of Asthma in Costa Rica$1,399,348
R37 · FY2015 · HL · contact PI
EMERGE PHASE III CLINICAL CENTER AT PARTNERS HEALTHCARE$972,425
U01 · FY2015 · HG · contact PI
Integrative & Systems Genomics Core$477,732
P01 · FY2015 · HL · contact PI
CLINICAL EPIDEMIOLOGY OF LUNG DISEASES$404,146
T32 · FY2015 · HL · contact PI
SYSTEMS GENETICS AND GENOMICS OF LUNG DISEASES$269,998
K12 · FY2015 · HL · contact PI
The Genetic Epidemiology of Asthma in Costa Rica$2,960,920
R37 · FY2014 · HL · contact PI
RANDOMIZED CONTROLLED TRIAL: VDAART CONTINUATION STUDY - DCC - LEAD$2,067,659
R01 · FY2014 · HL · contact PI
Pharmacogenetics of Asthma Treatment$1,919,404
U01 · FY2014 · HL · contact PI
The Genetic Epidemiology of Asthma in Costa Rica$1,486,329
R37 · FY2014 · HL · contact PI
Integrative & Systems Genomics Core$502,397
P01 · FY2014 · HL · contact PI
CLINICAL EPIDEMIOLOGY OF LUNG DISEASES$469,668
T32 · FY2014 · HL · contact PI
SYSTEMS GENETICS AND GENOMICS OF LUNG DISEASES$269,998
K12 · FY2014 · HL · contact PI
Pharmacogenetics of Asthma Treatment$1,864,564
U01 · FY2013 · HL · contact PI
Randomized Trial: Maternal Vitamin D Supplementation to Prevent Childhood Asthma$1,830,875
U01 · FY2013 · HL · contact PI
The Genetic Epidemiology of Asthma in Costa Rica$1,440,644
R37 · FY2013 · HL · contact PI
INTRAUTERINE SMOKE EXPOSURE AND ASTHMA: GENOMIC ORIGINS$548,765
R01 · FY2013 · HL · contact PI
CLINICAL EPIDEMIOLOGY OF LUNG DISEASES$353,889
T32 · FY2013 · HL · contact PI
SYSTEMS GENETICS AND GENOMICS OF LUNG DISEASES$124,198
K12 · FY2013 · HL · contact PI
Randomized Trial: Maternal Vitamin D Supplementation to Prevent Childhood Asthma$2,026,165
U01 · FY2012 · HL · contact PI
Pharmacogenetics of Asthma Treatment$1,958,575
U01 · FY2012 · HL · contact PI
The Genetic Epidemiology of Asthma in Costa Rica$1,541,378
R37 · FY2012 · HL · contact PI
INTRAUTERINE SMOKE EXPOSURE AND ASTHMA: GENOMIC ORIGINS$583,524
R01 · FY2012 · HL · contact PI
CLINICAL EPIDEMIOLOGY OF LUNG DISEASES$404,037
T32 · FY2012 · HL · contact PI
Translational Genetics and Genomics of Airways Diseases$291,600
K12 · FY2012 · HL · contact PI
Randomized Trial: Maternal Vitamin D Supplementation to Prevent Childhood Asthma$54,667
U01 · FY2012 · HL · contact PI
Common Genetic Determinants of Asthma and COPD-PROGRAM PROJECT$2,366,332
P01 · FY2011 · HL · contact PI
Randomized Trial: Maternal Vitamin D Supplementation to Prevent Childhood Asthma$2,026,165
U01 · FY2011 · HL · contact PI
Pharmacogenetics of Asthma Treatment$1,957,381
U01 · FY2011 · HL · contact PI
The Genetic Epidemiology of Asthma in Costa Rica$1,193,388
R37 · FY2011 · HL · contact PI
INTRAUTERINE SMOKE EXPOSURE AND ASTHMA: GENOMIC ORIGINS$600,293
R01 · FY2011 · HL · contact PI
CLINICAL EPIDEMIOLOGY OF LUNG DISEASES$470,858
T32 · FY2011 · HL · contact PI
Genetic Association in Human Asthma Populations$134,038
P01 · FY2011 · HL · contact PI
Administration$104,298
P01 · FY2011 · HL · contact PI
The Asthma BioRepository for Integrative Genomics Research$4,236,197
RC2 · FY2010 · HL
Common Genetic Determinants of Asthma and COPD-PROGRAM PROJECT$2,410,042
P01 · FY2010 · HL · contact PI
Randomized Trial: Maternal Vitamin D Supplementation to Prevent Childhood Asthma$2,015,731
U01 · FY2010 · HL · contact PI
Pharmacogenetics of Asthma Treatment$1,992,800
U01 · FY2010 · HL · contact PI
The Genetic Epidemiology of Asthma in Costa Rica$1,146,798
R37 · FY2010 · HL · contact PI
INTRAUTERINE SMOKE EXPOSURE AND ASTHMA: GENOMIC ORIGINS$586,422
R01 · FY2010 · HL · contact PI
Translational Genetics and Genomics of Airways Diseases$399,600
K12 · FY2010 · HL · contact PI
Clinical Epidemiology of Lung Diseases$260,329
T32 · FY2010 · HL · contact PI
Genetic Association in Human Asthma Populations$131,723
P01 · FY2010 · HL · contact PI
Administration$102,495
P01 · FY2010 · HL · contact PI
The Asthma BioRepository for Integrative Genomics Research$4,110,614
RC2 · FY2009 · HL
Pharmacogenetics of Asthma Treatment$3,192,109
U01 · FY2009 · HL · contact PI
Common Genetic Determinants of Asthma and COPD: PROGRAM PROJECT$2,452,908
P01 · FY2009 · HL · contact PI
Randomized Trial: Maternal Vitamin D Supplementation to Prevent Childhood Asthma$2,060,104
U01 · FY2009 · HL · contact PI
The Genetic Epidemiology of Asthma in Costa Rica$1,288,008
R37 · FY2009 · HL · contact PI
INTRAUTERINE SMOKE EXPOSURE AND ASTHMA: GENOMIC ORIGINS$619,897
R01 · FY2009 · HL · contact PI
Clinical Epidemiology of Lung Diseases$579,401
T32 · FY2009 · HL · contact PI
Translational Genetics and Genomics of Airways Diseases$399,600
K12 · FY2009 · HL · contact PI
Genetic Association in Human Asthma Populations$131,717
P01 · FY2009 · HL · contact PI
Administration$102,490
P01 · FY2009 · HL · contact PI
Pharmacogenetics of Asthma Treatment$3,127,710
U01 · FY2008 · HL · contact PI
Common Genetic Determinants of Asthma and COPD - PROGRAM PROJECT$2,512,422
P01 · FY2008 · HL · contact PI
The Genetic Epidemiology of Asthma in Costa Rica$875,348
R37 · FY2008 · HL · contact PI
Clinical Epidemiology of Lung Diseases$627,701
T32 · FY2008 · HL · contact PI
Translational Genetics and Genomics of Airways Diseases$399,600
K12 · FY2008 · HL · contact PI
Genetic Association in Human Asthma Populations$132,168
P01 · FY2008 · HL · contact PI
Administration$103,281
P01 · FY2008 · HL · contact PI
Pharmacogenetics of Asthma Treatment$3,190,981
U01 · FY2007 · HL · contact PI
Common Genetic Determinants of Asthma and COPD - PROGRAM PROJECT$2,462,000
P01 · FY2007 · HL · contact PI
The Genetic Epidemiology of Asthma in Costa Rica$1,235,207
R37 · FY2007 · HL · contact PI
Clinical Epidemiology of Lung Diseases$537,377
T32 · FY2007 · HL · contact PI
Translational Genetics and Genomics of Airways Diseases$399,600
K12 · FY2007 · HL · contact PI
Genetic Association in Human Asthma Populations$155,323
P01 · FY2007 · HL · contact PI
Administration$121,965
P01 · FY2007 · HL · contact PI
Pharmacogenetics of Asthma Treatment$3,285,718
U01 · FY2006 · HL · contact PI
Clinical Epidemiology of Lung Diseases$489,385
T32 · FY2006 · HL · contact PI
Pharmacogenetics of Asthma Treatment$3,361,644
U01 · FY2005 · HL
THE GENETIC EPIDEMIOLOGY OF ASTHMA IN COSTA RICA$961,818
R01 · FY2005 · HL
Fine mapping of chromosome 12Q genes for asthma in CAMP$498,891
P50 · FY2005 · HL
THE PHARMACOGENETICS OF ASTHMA TREATMENT$1,618,806
U01 · FY2004 · HL
THE GENETIC EPIDEMIOLOGY OF ASTHMA IN COSTA RICA$1,137,615
R01 · FY2004 · HL
Clinical Epidemiology of Lung Diseases$406,786
T32 · FY2004 · HL
ADMINISTRATIVE/EDUCATION CENTER FOR INNATE IMMUNITY PGA$103,800
U01 · FY2004 · HL
THE PHARMACOGENETICS OF ASTHMA TREATMENT$2,840,148
U01 · FY2003 · HL
THE GENETIC EPIDEMIOLOGY OF ASTHMA IN COSTA RICA$1,167,785
R01 · FY2003 · HL
ADMINISTRATIVE/EDUCATION CENTER FOR INNATE IMMUNITY PGA$494,623
U01 · FY2003 · HL
Scientific Oversight$319,724
U01 · FY2003 · HL
CLINICAL EPIDEMIOLOGY OF LUNG DISEASES$264,587
T32 · FY2003 · HL
THE PHARMACOGENETICS OF ASTHMA TREATMENT$2,673,360
U01 · FY2002 · HL
THE GENETIC EPIDEMIOLOGY OF ASTHMA IN COSTA RICA$1,202,593
R01 · FY2002 · HL
Fine mapping of chromosome 12Q genes for asthma in CAMP$487,054
P50 · FY2002 · HL
ADMINISTRATIVE/EDUCATION CENTER FOR INNATE IMMUNITY PGA$477,420
U01 · FY2002 · HL
CLINICAL EPIDEMIOLOGY OF LUNG DISEASES$394,332
T32 · FY2002 · HL
THE PHARMACOGENETICS OF ASTHMA TREATMENT$229,773
U01 · FY2002 · HL
DIET, IMMUNE MODULATION, AND ASTHMA IN EARLY LIFE$53,530
R01 · FY2002 · HL
THE PHARMACOGENETICS OF ASTHMA TREATMENT$2,715,995
U01 · FY2001 · HL
THE GENETIC EPIDEMIOLOGY OF ASTHMA IN COSTA RICA$700,670
R01 · FY2001 · HL
ADMINISTRATIVE/EDUCATION CENTER FOR INNATE IMMUNITY PGA$460,884
U01 · FY2001 · HL
CLINICAL EPIDEMIOLOGY OF LUNG DISEASES$370,833
T32 · FY2001 · HL
DIET, IMMUNE MODULATION, AND ASTHMA IN EARLY LIFE$296,625
R01 · FY2001 · HL
Fine mapping of chromosome 12Q genes for asthma in CAMP$0
P01 · FY2001 · HL
PHARMACOGENETICS OF ASTHMA TREATMENT$2,617,873
U01 · FY2000 · HL
CLINICAL CENTER FOR CAMP$1,000,000
N01 · FY2000 · HR
FINE MAPPING OF CHROMOSOME 12Q GENES FOR ASTHMA IN CAMP$541,125
R01 · FY2000 · HL
ADMINISTRATIVE/EDUCATION CENTER FOR INNATE IMMUNITY PGA$399,739
U01 · FY2000 · HL
EPIDEMIOLOGY OF AIRWAYS RESPONSIVENESS$395,133
R01 · FY2000 · HL
CLINICAL EPIDEMIOLOGY OF LUNG DISEASES$357,281
T32 · FY2000 · HL
DIET, IMMUNE MODULATION, AND ASTHMA IN EARLY LIFE$296,625
R01 · FY2000 · HL